FOX04 -DRI

TL;DR: Understanding FOX04-DRI Peptide

FOX04-DRI is a synthetically derived peptide studied for its potential role in targeted cellular processes, particularly in mitigating cellular senescence. Research indicates that it may be of interest for advancing senescence-related biological studies.

Key Research Benefits

Studies suggest several key effects of FOX04-DRI:

• May help facilitate the removal of senescent cells without inducing damage to healthy cells.
• Could support research into cellular aging and regenerative biology.
• Research points to potential relevance in the study of age-related health conditions.
• Offers a tool for investigating mechanisms linked to DNA repair and apoptosis pathways.

Mechanism of Action (Simplified)

FOX04-DRI interacts with the p53 pathway, a critical regulator of cellular apoptosis and senescence. By binding specifically to FOXO4, it interrupts its interaction with p53, allowing targeted removal of impaired cells while sparing normal ones. This process is hypothesized to delay cellular aging, serving as a promising subject for senescence-focused research.

Technical & Storage Specifications

Specifications:

Purity	>99%
Appearance	White Lyophilized Powder
Storage (Unopened)	-20°C
Storage (Reconstituted)	4°C (Short Term) or -20°C (Long Term)

Frequently Asked Questions

What is the difference between FOX04-DRI and similar peptides?

FOX04-DRI is specific in its mechanism, primarily targeting the p53 pathway through FOXO4 binding. This makes it distinct from other peptides addressing senescence or apoptosis.

How should it be stored after reconstitution?

After reconstitution, FOX04-DRI should be stored at 4°C for short-term use or at -20°C for long-term stability to maintain its viability in research applications.

Is third-party testing (CoA) available?

Yes, third-party Certificates of Analysis (CoA) are provided to ensure transparency and quality compliance for all batches.